Quote:

---

Is 350m enough to start/finish a trial, Nash? Cancer?
No, it is not,

---

If the average share price over the next year is .40 and the actual return after warrants and Paulson payments is .30 then that means $105 million. I would expect ongoing expenses including Samsung around $3 - $4 million a month, so at worst $48 million in the next year. Do you really think a 500 patient, 1 year NASH trial is going to cost more than $57 million. I think it will cost substantially less.